SOLUTION STRUCTURE OF THE SH3 DOMAIN OF SRC AND IDENTIFICATION OF ITS LIGAND-BINDING SITE

被引:304
|
作者
YU, HT
ROSEN, MK
SHIN, TB
SEIDELDUGAN, C
BRUGGE, JS
SCHREIBER, SL
机构
[1] HARVARD UNIV,DEPT CHEM,CAMBRIDGE,MA 02138
[2] ARIAD PHARMACEUT INC,CAMBRIDGE,MA 02139
关键词
D O I
10.1126/science.1280858
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Src homology 3 (SH3) region is a protein domain of 55 to 75 amino acids found in many cytoplasmic proteins, including those that participate in signal transduction pathways. The solution structure of the SH3 domain of the tyrosine kinase Src was determined by multidimensional nuclear magnetic resonance methods. The molecule is composed of two short three-stranded anti-parallel beta sheets packed together at approximately right angles. Studies of the SH3 domain bound to proline-rich peptide ligands revealed a hydrophobic binding site on the surface of the protein that is lined with the side chains of conserved aromatic amino acids.
引用
收藏
页码:1665 / 1668
页数:4
相关论文
共 50 条
  • [31] Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src
    Zhiwei Shen
    Andreas Batzer
    Jackie A Koehler
    Paul Polakis
    Joseph Schlessinger
    Nicholas B Lydon
    Michael F Moran
    Oncogene, 1999, 18 : 4647 - 4653
  • [32] Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src
    Shen, ZW
    Batzer, A
    Koehler, JA
    Polakis, P
    Schlessinger, J
    Lydon, NB
    Moran, MF
    ONCOGENE, 1999, 18 (33) : 4647 - 4653
  • [33] Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth
    A Migliaccio
    L Varricchio
    A De Falco
    G Castoria
    C Arra
    H Yamaguchi
    A Ciociola
    M Lombardi
    R Di Stasio
    A Barbieri
    A Baldi
    M V Barone
    E Appella
    F Auricchio
    Oncogene, 2007, 26 : 6619 - 6629
  • [34] Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth
    Migliaccio, A.
    Varricchio, L.
    De Falco, A.
    Castoria, G.
    Arra, C.
    Yamaguchi, H.
    Ciociola, A.
    Lombardi, M.
    Di Stasio, R.
    Barbieri, A.
    Baldi, A.
    Barone, M. V.
    Appella, E.
    Auricchio, F.
    ONCOGENE, 2007, 26 (46) : 6619 - 6629
  • [35] High resolution crystal structure of the FAK FERM domain reveals new insights on the Druggability of tyrosine 397 and the Src SH3 binding site
    Timothy Marlowe
    Alexey Dementiev
    Sheila Figel
    Andrew Rivera
    Michael Flavin
    William Cance
    BMC Molecular and Cell Biology, 20
  • [36] High resolution crystal structure of the FAK FERM domain reveals new insights on the Druggability of tyrosine 397 and the Src SH3 binding site
    Marlowe, Timothy
    Dementiev, Alexey
    Figel, Sheila
    Rivera, Andrew
    Flavin, Michael
    Cance, William
    BMC MOLECULAR AND CELL BIOLOGY, 2019, 20
  • [37] Ligand-induced structural and dynamic changes in the C-Src SH3 domain
    Nicholson, LK
    Wang, C
    Cordier, F
    Pawley, N
    Grzesiek, S
    BIOPHYSICAL JOURNAL, 2000, 78 (01) : 481A - 481A
  • [38] STRUCTURE AND FUNCTION OF THE SH3 DOMAIN
    MUSACCHIO, A
    WILMANNS, M
    SARASTE, M
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1994, 61 (03): : 283 - 297
  • [39] The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding
    Martin A Broome
    Tony Hunter
    Oncogene, 1997, 14 : 17 - 34
  • [40] The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding
    Broome, MA
    Hunter, T
    ONCOGENE, 1997, 14 (01) : 17 - 34